Translating Aging
Translating Aging
Building the Infrastructure for Longevity Medicine: ARPA-H's PROSPR Program (Dr. Andrew Brack, Program Manager)
Loading
/

Building the Infrastructure for Longevity Medicine: ARPA-H’s PROSPR Program (Dr. Andrew Brack, Program Manager)

Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions for Prolonging Resilience), an ambitious new program aimed at extending human healthspan. In this wide-ranging conversation, Chris and Andrew explore how PROSPR plans to accelerate the development of therapies that target aging itself by building the regulatory and scientific infrastructure needed to measure and improve health during aging. They discuss PROSPR's innovative approaches to in-home data collection, biomarker development, and clinical trial design that could compress decades-long studies into just three years.

The Finer Details:

  • The mission and structure of ARPA-H as a catalyst for healthcare innovation
  • How PROSPR aims to build "train tracks" for the longevity therapeutics industry
  • The program's novel approach to measuring health through intrinsic capacity
  • Strategies for compressing clinical trials from decades to years
  • The economic impact of extending healthspan by just one year
  • Plans for first- and second-generation therapeutics targeting aging
  • The role of in-home health monitoring in future clinical trials

Quote:

"We have this moral imperative to close the gap between the length that we are living and the number of years that we're living in good health."

Links:

PROSPR website

Proposers' Day registration

More From Current Show

Matthew "Oki" O'Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new...
Listen Now
Marco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that...
Listen Now
Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe's most active longevity-focused venture capital...
Listen Now
In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay...
Listen Now
Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to...
Listen Now
Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with...
Listen Now
Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life...
Listen Now
Adam Freund (CEO) and Remi Laberge (CTO) are the founders of Arda Therapeutics, a biotechnology company developing novel...
Listen Now

Related Episodes

No related episodes found.